Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22690 | 372 | 32.1 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
1549 | 2 | CYCLOTIDES//BOWMAN BIRK INHIBITOR//TRYPSIN INHIBITOR | 7414 |
22690 | 1 | TUMOR ASSOCIATED TRYPSIN INHIBITOR//TATI//PEC 60 | 372 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR ASSOCIATED TRYPSIN INHIBITOR | authKW | 1427535 | 5% | 87% | 20 |
2 | TATI | authKW | 1034236 | 6% | 60% | 21 |
3 | PEC 60 | authKW | 492501 | 2% | 100% | 6 |
4 | SERINE PROTEASE INHIBITOR KAZAL TYPE 1 SPINK1 | authKW | 328334 | 1% | 100% | 4 |
5 | MESOTRYPSIN | authKW | 256507 | 1% | 63% | 5 |
6 | PANCREATIC SECRETORY TRYPSIN INHIBITOR | authKW | 183910 | 3% | 20% | 11 |
7 | BRAIN TRYPSIN | authKW | 164167 | 1% | 100% | 2 |
8 | DEGRADATION OF THE EXTRACELLULAR MATRIX | authKW | 164167 | 1% | 100% | 2 |
9 | HUMAN TRYPSINOGEN 4 | authKW | 164167 | 1% | 100% | 2 |
10 | LOW MW PROTEINS | authKW | 164167 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 609 | 22% | 0% | 83 |
2 | Medical Laboratory Technology | 482 | 6% | 0% | 23 |
3 | Gastroenterology & Hepatology | 415 | 11% | 0% | 40 |
4 | Medicine, Research & Experimental | 226 | 10% | 0% | 38 |
5 | Biochemistry & Molecular Biology | 209 | 23% | 0% | 86 |
6 | Pathology | 173 | 7% | 0% | 25 |
7 | Urology & Nephrology | 55 | 4% | 0% | 16 |
8 | Biophysics | 46 | 5% | 0% | 19 |
9 | Cell Biology | 43 | 8% | 0% | 28 |
10 | Physiology | 15 | 3% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GASTROENTEROL HEMATOL ONCOL RHEUMATOL | 109443 | 1% | 67% | 2 |
2 | BARTS THE LONDON MED | 82084 | 0% | 100% | 1 |
3 | BIOCHEM MOL GENETPROT NETWORK | 82084 | 0% | 100% | 1 |
4 | CANC UNITED KINGDON LONDON | 82084 | 0% | 100% | 1 |
5 | CLIN HORMONE S | 82084 | 0% | 100% | 1 |
6 | DENTBIOMED ORAL PATHOL UNIT | 82084 | 0% | 100% | 1 |
7 | EMI 0115ETAB FRANCAIS SANG BRETAGNE | 82084 | 0% | 100% | 1 |
8 | ENDOCRINE PANCREAS TRANSPLANT UNIT | 82084 | 0% | 100% | 1 |
9 | GRP RECH TROPHICITE VIEILLISSEMENT | 82084 | 0% | 100% | 1 |
10 | HLTH SCI WARSAW | 82084 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 8822 | 6% | 0% | 22 |
2 | INTERNATIONAL JOURNAL OF PANCREATOLOGY | 1416 | 1% | 0% | 4 |
3 | JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION | 1365 | 1% | 0% | 5 |
4 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 1282 | 2% | 0% | 6 |
5 | PANCREATOLOGY | 1062 | 1% | 0% | 4 |
6 | HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE | 920 | 1% | 0% | 3 |
7 | CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES | 844 | 1% | 1% | 2 |
8 | CLINICA CHIMICA ACTA | 730 | 3% | 0% | 10 |
9 | TUMOR BIOLOGY | 644 | 2% | 0% | 7 |
10 | CLINICAL CHEMISTRY | 551 | 2% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUMOR ASSOCIATED TRYPSIN INHIBITOR | 1427535 | 5% | 87% | 20 | Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR | Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR |
2 | TATI | 1034236 | 6% | 60% | 21 | Search TATI | Search TATI |
3 | PEC 60 | 492501 | 2% | 100% | 6 | Search PEC+60 | Search PEC+60 |
4 | SERINE PROTEASE INHIBITOR KAZAL TYPE 1 SPINK1 | 328334 | 1% | 100% | 4 | Search SERINE+PROTEASE+INHIBITOR+KAZAL+TYPE+1+SPINK1 | Search SERINE+PROTEASE+INHIBITOR+KAZAL+TYPE+1+SPINK1 |
5 | MESOTRYPSIN | 256507 | 1% | 63% | 5 | Search MESOTRYPSIN | Search MESOTRYPSIN |
6 | PANCREATIC SECRETORY TRYPSIN INHIBITOR | 183910 | 3% | 20% | 11 | Search PANCREATIC+SECRETORY+TRYPSIN+INHIBITOR | Search PANCREATIC+SECRETORY+TRYPSIN+INHIBITOR |
7 | BRAIN TRYPSIN | 164167 | 1% | 100% | 2 | Search BRAIN+TRYPSIN | Search BRAIN+TRYPSIN |
8 | DEGRADATION OF THE EXTRACELLULAR MATRIX | 164167 | 1% | 100% | 2 | Search DEGRADATION+OF+THE+EXTRACELLULAR+MATRIX | Search DEGRADATION+OF+THE+EXTRACELLULAR+MATRIX |
9 | HUMAN TRYPSINOGEN 4 | 164167 | 1% | 100% | 2 | Search HUMAN+TRYPSINOGEN+4 | Search HUMAN+TRYPSINOGEN+4 |
10 | LOW MW PROTEINS | 164167 | 1% | 100% | 2 | Search LOW+MW+PROTEINS | Search LOW+MW+PROTEINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ITKONEN, O , STENMAN, UH , (2014) TATI AS A BIOMARKER.CLINICA CHIMICA ACTA. VOL. 431. ISSUE . P. 260 -269 | 91 | 54% | 4 |
2 | PAJU, A , STENMAN, UH , (2006) BIOCHEMISTRY AND CLINICAL ROLE OF TRYPSINOGENS AND PANCREATIC SECRETORY TRYPSIN INHIBITOR.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 43. ISSUE 2. P. 103-142 | 103 | 53% | 49 |
3 | RASANEN, K , ITKONEN, O , KOISTINEN, H , STENMAN, UH , (2016) EMERGING ROLES OF SPINK1 IN CANCER.CLINICAL CHEMISTRY. VOL. 62. ISSUE 3. P. 449 -457 | 54 | 70% | 0 |
4 | HAGSTROM, J , KOSKENSALO, S , STENMAN, UH , LOUHIMO, J , HAGLUND, C , (2012) TUMOUR-ASSOCIATED TRYPSIN INHIBITOR TATI IS A PROGNOSTIC MARKER IN COLORECTAL CANCER.ONCOLOGY. VOL. 82. ISSUE 4. P. 234 -241 | 34 | 81% | 8 |
5 | IDA, S , OZAKI, N , ARAKI, K , HIRASHIMA, K , ZAITSU, Y , TAKI, K , SAKAMOTO, Y , MIYAMOTO, Y , OKI, E , MORITA, M , ET AL (2015) SPINK1 STATUS IN COLORECTAL CANCER, IMPACT ON PROLIFERATION, AND ROLE IN COLITIS-ASSOCIATED CANCER.MOLECULAR CANCER RESEARCH. VOL. 13. ISSUE 7. P. 1130 -1138 | 31 | 72% | 5 |
6 | STENMAN, UH , (2002) TUMOR-ASSOCIATED TRYPSIN INHIBITOR.CLINICAL CHEMISTRY. VOL. 48. ISSUE 8. P. 1206 -1209 | 34 | 76% | 46 |
7 | HOTAKAINEN, K , BJARTELL, A , SANKILA, A , JARVINEN, R , PAJU, A , RINTALA, E , HAGLUND, C , STENMAN, UH , (2006) DIFFERENTIAL EXPRESSION OF TRYPSINOGEN AND TUMOR-ASSOCIATED TRYPSIN INHIBITOR (TATI) IN BLADDER CANCER.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 28. ISSUE 1. P. 95-101 | 27 | 87% | 17 |
8 | STENMAN, UH , (2016) BIOMARKER DEVELOPMENT, FROM BENCH TO BEDSIDE.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 53. ISSUE 2. P. 69 -86 | 52 | 29% | 3 |
9 | GABER, A , JOHANSSON, M , STENMAN, UH , HOTAKAINEN, K , PONTEN, F , GLIMELIUS, B , BJARTELL, A , JIRSTROM, K , BIRGISSON, H , (2009) HIGH EXPRESSION OF TUMOUR-ASSOCIATED TRYPSIN INHIBITOR CORRELATES WITH LIVER METASTASIS AND POOR PROGNOSIS IN COLORECTAL CANCER.BRITISH JOURNAL OF CANCER. VOL. 100. ISSUE 10. P. 1540 -1548 | 28 | 58% | 35 |
10 | PAJU, A , VARTIAINEN, J , HAGLUND, C , ITKONEN, O , VON BOGUSLAWSKI, K , LEMINEN, A , WAHLSTROM, T , STENMAN, UH , (2004) EXPRESSION OF TRYPSINOGEN-1, TRYPSINOGEN-2, AND TUMOR-ASSOCIATED TRYPSIN INHIBITOR IN OVARIAN CANCER: PROGNOSTIC STUDY ON TISSUE AND SERUM.CLINICAL CANCER RESEARCH. VOL. 10. ISSUE 14. P. 4761-4768 | 29 | 64% | 32 |
Classes with closest relation at Level 1 |